STOCK TITAN

Covista (CVSA) Stock News

CVSA NYSE

Welcome to our dedicated page for Covista news (Ticker: CVSA), a resource for investors and traders seeking the latest updates and insights on Covista stock.

Covista Inc. reports news centered on healthcare education enrollment, institutional performance, earnings results, fiscal guidance and strategy updates for its portfolio of accredited institutions. Recurring company developments include Chamberlain University enrollment trends, Walden University growth, medical-school residency outcomes for AUC and Ross graduates, and initiatives tied to healthcare workforce demand.

Covista news also covers technology-enabled education, healthcare AI credentials, partnerships with healthcare and technology organizations, leadership responsibilities, investor-day strategy materials, capital allocation and the company's completed transition to the CVSA ticker on the New York Stock Exchange.

Rhea-AI Summary

Covista (NYSE: CVSA) will release third quarter fiscal 2026 results on Thursday, May 7, 2026 after market close, followed by a conference call at 4:00 p.m. CT / 5:00 p.m. ET.

Investors can join by phone using provided U.S. and international numbers or listen via the Covista investor relations website. A replay will be available for 30 days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
conferences
-
Rhea-AI Summary

Covista (NYSE: CVSA) promoted Michael Betz to Chief Growth & Innovation Officer on April 6, 2026, expanding his remit to include oversight of Marketing while he retains his role as President of Walden University and head of Digital. The move unifies marketing, digital and innovation to accelerate student engagement and growth.

Covista serves more than 97,000 students and 385,000 alumni across five accredited institutions; the company said Maurice Herrera will step down as Chief Marketing Officer amid the reorganization.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.59%
Tags
none
-
Rhea-AI Summary

Uplift Investors (NYSE:ATGE) appointed Evan Trent as Chief Strategy Officer on March 10, 2026. Based in Chicago, Trent will lead the firm’s M&A and Integration Value Creation Center and oversee internal deployment of Uplift’s strategic plan.

Trent brings 25+ years of experience across private equity-backed, startup, and public companies, including senior roles at Covista, Harbor Global, Heidrick & Struggles, and Sterling Partners. The hire follows Uplift’s first platform investment, Orion Legal MSO, announced in January 2026, and aligns with its 5-5-5 Framework for targeting business models, services sectors, and value-creation initiatives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.95%
Tags
none
Rhea-AI Summary

NYSE (NYSE:ICE) issued its pre-market update for Feb 24, 2026, highlighting market movers, corporate events and executive changes ahead of trading.

Key items: President Trump's 10% global levies took effect, Amer Sports reported 27% revenue growth in 2025, and AI data platform DDN named Guido Torrini as chief financial operating officer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
-
Rhea-AI Summary

Covista (NYSE:ATGE) unveiled Purpose at Scale, a three-year growth plan to expand healthcare workforce capacity and AI-enabled education.

The company reported 97,000 students (up from ~76,000), 24,000 graduates last year, and provided FY26 guidance of $1.90–$1.94B revenue and $7.80–$8.00 adjusted EPS. Covista also set FY27–FY29 revenue and adjusted EPS growth targets and announced partnerships with GE Healthcare HelloAI and SAIC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of Covista (CVSA)?

The current stock price of Covista (CVSA) is $115.84 as of July 25, 2026.

What is the market cap of Covista (CVSA)?

The market cap of Covista (CVSA) is approximately 3.9B.